contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


resolutions-from-the-annual-general-meeting-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.

Novonesis

Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2025Approval of distribution of profit...

Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: <ul><li>Approval of the audited Annual Report for 2025</li><li>Approval of distribution of profit with payment of an ordinary dividend of DKK 4.25 (corresponding to approximately EUR 0.57) per A and B share. In addition to this year-end dividend, an interim dividend of DKK 2.25 (corresponding to approximately EUR 0.3) was disbursed on August 27, 2025</li><li>Approval of the Remuneration Report for 2025 (advisory vote)</li><li>Approval of the remuneration of members of the Board of Directors for 2026</li><li>Re-election of Cornelis (Cees) de Jong as Chair of the Board of Directors</li><li>Re-election of Heine Dalsgaard as Vice Chair of the Boad of Directors</li><li>Re-election of Lise Kaae, Monila Kothari, Kasim Kutay, Kevin Lane, Morten Otto Alexander Sommer, and Kim Stratton as members of the Board of Directors</li><li>Re-election of EY Godkendt Revisionspartnerselskab as the company’s auditors in respect of statutory financial and sustainability reporting</li><li>Approval to renew the authorizations to the Board of Directors to implement capital increases</li><li>Approval to renew the authorization to the Board of Directors to acquire treasury shares</li><li>Approval of the authorization to the Board of Directors to distribute extraordinary dividends</li><li>The shareholder proposal was withdrawn</li></ul> Composition of the Board of Directors and its committees After the Annual General Meeting, the Board of Directors held a board meeting to appoint members of its committees. The Board of Directors, including its committees, continues to be composed as follows: <ul><li>Cees (Cornelis) de Jong (Chair of the Board, chair of the Nomination and Remuneration Committee and member of the Audit Committee)</li><li>Heine Dalsgaard (Vice Chair of the Board and member of the Audit Committee)</li><li>Robert Nøddeskov Jensen (employee representative)</li><li>Lise Kaae (chair of the Audit Committee)</li><li>Monila Kothari (member of the Innovation Committee)</li><li>Kasim Kutay (member of the Nomination and Remuneration Committee)</li><li>Lars Bo Køppler (employee representative and member of the Nomination and Remuneration Committee)</li><li>Kevin Lane (member of the Innovation Committee)</li><li>Preben Nielsen (employee representative and member of the Innovation Committee)</li><li>Frederikke Rose Spenner (employee representative)</li><li>Morten Otto Alexander Sommer (chair of the Innovation Committee)</li><li>Kim Stratton (member of the Nomination and Remuneration Committee)</li></ul> For further information on the members of the Board of Directors, please go to <a href="https://www.globenewswire.com/Tracker?data=SQ00y0YjaD0s_gnWKk6bhuO9LoPOs8bH5xUgUYPcxikdm-gpX1Mae76Wg7HP9Qx1br9kXtkzeYdbFT6vdwvznXUwckqdpQ2uDctsfYJmuRY=">www.novonesis.com</a> Attachment<ul> <li> <a href="https://ml-eu.globenewswire.com/Resource/Download/01e7e1ea-d193-48a9-a262-876f1a4b759d">2026_09_AGM_Resolutions</a> </li> </ul><img alt="" src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTE3MTcyNSM0MDIzNjI5NzIjMjAwMjM5NA=="> <img alt="" src="https://ml-eu.globenewswire.com/media/Y2YzMWIxMmQtOGFkYS00OWI5LThiYTAtZjFhOTMxZGI2YjgxLTEwMTM5NjctMjAyNi0wMy0yMy1lbg==/tiny/Novonesis-Novozymes-A-S-.png">

Resolutions from the Annual General Meeting 2026

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Nordea Bank

Nordea shareholder? It’s easier than ever to attend the AGM with a new digital set-up

Return on capital (ROE, ROI, ROIC, RONIC)

Balance sheet, debt leverage and risks